Validation of Alternative Methods for the Potency Testing of Vaccines: The Report and Recommendations of ECVAM Workshop 31

ATLA Alternatives to Laboratory Animals

Volumn 26, Issue 6, 1998, Pages 747-761

  Hendriksen, Coenraad ^a   Spieser, Jean Marc ^b   Akkermans, Arnoud ^a   Balls, Michael ^c   Bruckner, Lukas ^d   Cussler, Klaus ^e   Daas, Arnold ^b   Descamps, Johan ^f   Dobbelaer, Roland ^g   Fentem, Julia ^c   Halder, Marlies ^c   Van Der Kamp, Margot ^h   Lucken, Roger ⁱ   Milstien, Julie ^j   Sesardic, Dorothea ^k   Straughan, Donald ^l   Valadares, Antonio ^m  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b European Network of National Information Centers   (France)

^c JOINT RESEARCH CENTRE   (Italy)

^d INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

^e PAUL EHRLICH INSTITUT   (Germany)

^f GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^g SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^h Netherlands Ctr Alternatives A   (Netherlands)

ⁱ Cross Inn   (United Kingdom)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

^k NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^l Laborotono Natl Investigacao Vet ^*  (United Kingdom)

^m Laborotono Natl Investigacao Vet   (Portugal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2542635812     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ECVAM (1994), ECVAM News & Views. ATLA 22, 7-11.
2. Russell, W.M.S. & Burch R.L. (1959). The Principles of Humane Experimental Technique. 238pp. London, UK, Methuen.
3. WHO (1992). WHO Technical Report Series No. 882. Guidelines for national authorities on quality assurance for biological products, pp. 31-44. Geneva, Switzerland: WHO
4. WHO (1997) General introduction. In Manual of Laboratory Methods for Potency Testing of Vaccines Used in the WHO Expanded Programme on Immunisation. WHO/VSQ/97 04, pp. 3-12. Geneva, Switzerland: WHO.
5. Griffiths, E (1996). Assuring the quality of vaccines: regulatory requirements for licensing and batch release. In Methods in Molecular Medicine: Vaccine Protocols (ed. A Robinson, G Farrar & C. Wiblin) pp. 269-288. Totowa, NJ, USA. Humana Press.
6. Shewhart, W.A (1931). Economic Control of Quality of Manufactured Products, 495pp. New York, USA. Nostrand.
7. Anon (1991) Minitab Statistical Software Release 8, QC Supplement. Quality Control and Improvement, pp 21.15-21.20. Rosemont, PA, USA. Quickset.
8. Rowlands, R.J , Wilson, D W., Nix, A.B., Kemp, KW & Griffiths, K (1980) Advantages of CUSUM techniques for quality control in clinical chemistry Clinica Chimica Acta 108, 393-397.
9. Finney, D J. (1964) Control charts In Statistical Methods in Biological Assay, pp. 161-162. London, UK Charles Griffin & Company Limited.
10. Hendriksen, C F M, Garthoff, B , Aggerbeck, H , Bruckner, L , Castle, P., Cussler, K , Dobbelaer, R , van de Donk, H , van der Gun, J W , Lefrancois, S , Milstien, J , Minor, P D , Mougeot, H , Rombaut, B , Ronneberger, H D , Spieser, J-M , Stolp, R , Straughan, D W , Tolhs, M. & Zigtermans. G (1994) Alternatives to animal testing in the quality control of immunobiologicals current status and future prospects The report and recommendations of ECVAM workshop 4 ATLA 22, 420-434
11. Sesardic, D. (1996) Requirements for valid alternative assays for testing of biological therapeutic agents. Developments in Biological Standardisation 86, 311-318
12. Anco, A , Gross, R., Smida, J & Rappuoh, R. (1987) Evolutionary relationship in the genus Bordeteila Molecular Microbiology 1, 301-308
13. Council of Europe (1998) Feline leukaemia vaccine (inactivated) In European Pharmacopoeia, 3rd Edition, Suppl 2. Strasbourg, France. Council of Europe
14. Council of Europe (1997) Rabies vaccine (inactivated) for veterinary use In European Pharmacopoeia, 3rd Edition. Strasbourg, France: Council of Europe.
15. Hendriksen, C.F.M., Woltjes, J., Akkermans, A.M., van der Gun, J.W., Marsman, F.R., Verschure M.H & Veldman, K. (1994). Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use. Biologicals 22, 257-268
16. EDQM (1997). Alternative potency testing and other possible related quality issues for veterinary clostndial vaccines. Pharmeuropa, Special Issue, Bio 97-1. Strasbourg, France: European Department for the Quality of Medicines.
17. Beckmann, R. & Cussler, K. (1994). Potency testing of erysipelas vaccines in mice. ELISA versus challenge. ALTEX 11, SuppL, 39-45.
18. Council of Europe. (1997). Tetanus vaccine for veterinary use. In European Pharmacopoeia, 3rd Edition. Strasbourg, France: Council of Europe.
19. Balls, M., Blaauboer, B.J , Fentem, J.H., Bruner, L., Combes, R.D., Ekwall, B., Fielder, R.J., Guillouzo, A , Lewis, R.W , Lovell D.P., Reinhardt, C.A., Repetto, G., Sladowski, D., Spielmann, H. & Zucco, F. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. ATLA 23, 129-147.
20. Balls, M & Karcher, W. (1995). The validation of alternative test methods, ATLA 23, 884-886.
21. Fentem, J. & Balls, M. (1997). The ECVAM approach to validation. In Animal Alternatives, Welfare and Ethics (ed. L.F M. van Zutphen & M. Balls), pp. 1083-1089. Amsterdam, The Netherlands: Elsevier.
22. Curren, R.D., Southee J.A., Spielmann, H., Liebsch M., Fentem, J H & Balls, M. (1995). The role of prevalidation in the development, validation and acceptance of alternative methods. ATLA 23, 211-217
23. Balls, M., Blaauboer, B., Brusick, D., Frazier, J., Lamb, D , Pemberton, M , Remhardt, C., Roberfroid, M , Rosenkranz, H , Schmid, B., Spielmann, H , Stammati, A-L. & Walum, E. (1990). Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures ATLA 18, 313-337
24. Fentem, J.H., Prinsen, M K., Spielmann, H., Walum, E & Botham, P.A (1995). Validation. lessons learned from practical experience Toxicology in Vitro 9, 857-862.
25. WHO (1997). Validation of potency assays for toxoid vaccines based on in vitro methods for measuring antitoxin in the sera of vaccinated animals. In Manual of Laboratory Methods for Potency Testing of Vaccines Used in the WHO Expanded Programme on Immunization, pp 175-178. WHO/VSQ/97 04 Geneva, Switzerland. WHO.
26. Council of Europe (1996) Analytical Validation. In Pharmeuropa Technical Guide, pp 28-40. Strasbourg, France Council of Europe
27. ICH (1995) Validation of Analytical Methods: Definitions and Technology. ICH Topic Q 2A (CPMP/ICH/381/95). London, UK ICH.
28. WHO Expert Committee on Biological Standardization (1990) Technical Report Series, Vol. 800, Requirements for Diphtheria, Tetanus, Pertussis and Combined Vaccines, pp. 87-179 Geneva, Switzerland: WHO